Your browser doesn't support javascript.
loading
Relationship of neutrophil-to-lymphocyte ratio, in addition to C-reactive protein, with cardiovascular events in patients with type 2 diabetes.
Hoes, Lukas L F; Riksen, Niels P; Geleijnse, Johanna M; de Groot, Mark C H; T van der Schouw, Yvonne; Visseren, Frank L J; Koopal, Charlotte.
Afiliación
  • Hoes LLF; Department of Vascular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Riksen NP; Department of Internal Medicine, Division of Vascular Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Geleijnse JM; Division of Human Nutrition and Health, Wageningen University and Research, Wageningen, the Netherlands.
  • de Groot MCH; Utrecht Patient Oriented Database, Central Diagnostic Laboratory, Division of Laboratory, Pharmacy, and Biogenetics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • T van der Schouw Y; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Visseren FLJ; Department of Vascular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: F.L.J.Visseren@umcutrecht.nl.
  • Koopal C; Department of Vascular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Diabetes Res Clin Pract ; 213: 111727, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38848966
ABSTRACT

AIM:

To quantify the relationship of neutrophil-to-lymphocyte ratio (NLR) with cardiovascular events and all-cause mortality in patients with type 2 diabetes (T2D), independent of C-reactive protein (CRP).

METHODS:

Patients with T2D from the UCC-SMART-cohort were studied using multivariable-adjusted Cox regression. The relationship of NLR and CRP with vascular events (cerebrovascular events, myocardial infarction and vascular death) and all-cause mortality was quantified.

RESULTS:

During 10,833 person-years, 232 vascular events and 302 deaths occurred in 1,239 patients with T2D. Risk of vascular events and all-cause mortality increased per standard deviation (SD) in NLR (hazard ratio (HR) 1.27; 95 % confidence interval (CI)1.11-1.46) and 1.15; 95 % CI1.02-1.30) after adjustment for CRP. CRP was not associated with vascular events after adjustment for NLR, (HR per SD 1.03; 95 % CI 0.90-1.19), but was associated with all-cause mortality (HR per SD 1.18; 95 % CI 1.04-1.33). Notably, NLR was related to vascular events in patients with CRP < 2 mg/L (HR per unit 1.45; 95 % CI 1.19-1.77).

CONCLUSION:

In patients with T2D, NLR is related to higher risk of CVD and all-cause mortality, independently from CRP. NLR is related to CVD even when CRP is low, indicating that NLR is a marker of CVD-risk in addition to CRP. Both NLR and CRP are independently related to all-cause mortality in T2D patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína C-Reactiva / Linfocitos / Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Neutrófilos Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Res Clin Pract Asunto de la revista: ENDOCRINOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Irlanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína C-Reactiva / Linfocitos / Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Neutrófilos Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Res Clin Pract Asunto de la revista: ENDOCRINOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Irlanda